Automatic Real-time Diagnosis of Gastric Mucosal Disease Using pCLE With Artificial Intelligence
1 other identifier
observational
951
1 country
1
Brief Summary
Probe-based confocal laser endomicroscopy (pCLE) is an endoscopic technique that enables real-time histological evaluation of gastric mucosal disease during ongoing endoscopy examination. However this requires much experience, which limits the application of pCLE. The investigators designed a computer-aided diagnosis program using deep neural network to make diagnosis automatically in pCLE examination and contrast its performance with endoscopists.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 16, 2018
CompletedFirst Posted
Study publicly available on registry
December 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2021
CompletedApril 1, 2022
March 1, 2022
3.2 years
December 16, 2018
March 20, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The diagnosis efficiency of Artificial Intelligence
The primary outcome is to test the diagnostic accuracy, sensitivity, specificity, PPV, NPV of the Artificial Intelligence for diagnosing gastric mucosal disease on real-time pCLE examination.
24 months
Secondary Outcomes (1)
Contrast the diagnosis efficiency of Artificial Intelligence with endoscopists
24 months
Study Arms (1)
lesions observed by pCLE
pCLE is used to distinguish the suspected lesions detected by white light endoscopy.
Interventions
When suspected lesion is observed using pCLE, endoscopist and AI will make a diagnosis independently. In addition, the endoscopist can not see the diagnosis of AI.
Eligibility Criteria
Consecutive patients who receive the upper gastrointestinal tract pCLE examination and screened that fulfill the eligibility criteria at Qilu Hospital, Shandong University will be enrolled into the study
You may qualify if:
- aged between 18 and 80;
- agree to give written informed consent.
You may not qualify if:
- Patients under conditions unsuitable for performing CLE including coagulopathy , impaired renal or hepatic function, pregnancy or breastfeeding, and known allergy to fluorescein sodium;
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopic unit of Qilu Hospital Shandong University
Jinan, Shandong, 250001, China
Related Publications (1)
Liu G, Li G, Li Z, Shao X, Ji R, Ma T, Zhang Y, Su J, Qi Q, Guo J, He Y, Yang X, Li Y, Zuo X. Deep learning-aided optical biopsy achieves whole-chain diagnosis of Correa cascade of gastric cancer: a prospective study. BMC Med. 2025 Sep 30;23(1):527. doi: 10.1186/s12916-025-04310-9.
PMID: 41029674DERIVED
Biospecimen
When a gastric mucosal lesion is found using white light endoscopy , endoscopist will observe this lesion using pCLE and then take biopsy for histology examination.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yanqing Li
Qilu Hospital of Shandong University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice president of QiLu Hospital
Study Record Dates
First Submitted
December 16, 2018
First Posted
December 21, 2018
Study Start
July 1, 2018
Primary Completion
September 29, 2021
Study Completion
September 29, 2021
Last Updated
April 1, 2022
Record last verified: 2022-03